Quantcast
Last updated on April 18, 2014 at 0:14 EDT

Latest Neuroimaging Stories

2012-08-15 02:26:20

WATERVILLE, Maine, Aug. 15, 2012 /PRNewswire/ -- Rockland Technimed Ltd., a pioneer in developing metabolic magnetic resonance imaging (MRI) media, today presented the latest research on the potential clinical applications of brain MRI performed with its patented imaging medium, Oxy-17(®). The presentation highlighted the use of Oxy-17(® )MRI to measure two key indicators of cerebral tissue function: cerebral metabolic rate of oxygen (CMRO(2)) and oxygen extraction fraction (OEF)....

2012-08-14 23:03:48

Researchers at the Mayo Clinic say a common condition called leukoaraiosis, made up of tiny areas in the brain that have been deprived of oxygen and appear as bright white dots on MRI scans, is not a harmless part of the aging process, but rather a disease that alters brain function in the elderly. Results of the study were published online, August 13, by the Radiological Society of North America in the journal Radiology. Oak Brook, IL (PRWEB) August 13, 2012 Researchers at the Mayo Clinic...

2012-08-09 00:47:09

Stressed volunteers use different strategies and brain regions Stressed and non-stressed persons use different brain regions and different strategies when learning. This has been reported by the cognitive psychologists PD Dr. Lars Schwabe and Professor Oliver Wolf from the Ruhr-Universität Bochum in the Journal of Neuroscience. Non-stressed individuals applied a deliberate learning strategy, while stressed subjects relied more on their gut feeling. "These results demonstrate...

New Device In Locating Brain Electrical Activity
2012-07-26 09:50:41

Researchers at Aalto University in Finland have developed the world's first device designed for mapping the human brain that combines whole-head magnetoencephalography (MEG) and magnetic resonance imaging (MRI) technology. MEG measures the electrical function and MRI visualizes the structure of the brain. The merging of these two technologies will produce unprecedented accuracy in locating brain electrical activity non-invasively. We expect that the new technology will improve the accuracy...

2012-07-24 02:29:17

MALVERN, Pa., July 24, 2012 /PRNewswire/ -- Siemens Healthcare (NYSE: SI) has announced that the MAGNETOM Spectra 3 Tesla MRI system has received clearance from the U.S. Food and Drug Administration (FDA). The latest addition to Siemens' internationally renowned portfolio of MRI solutions, the MAGNETOM Spectra system offers premium imaging at a reduced total cost of ownership compared to other scanners in this product range, providing hospitals and radiological institutes with easier access...

2012-07-22 23:00:06

Wearable Brain Monitoring Sensors Enable Significant Advances in Neuroscience. Potomac, MD (PRWEB) July 22, 2012 fNIR Devices announced today that they will be featured in an upcoming episode of the Discovery Channel´s Health Heroes, a television series that gives viewers an in-depth look at some of today´s most exciting medical technologies and clinical treatments. fNIR Devices is a manufacturer of portable, functional near infrared (fNIR) brain imaging systems that measure...

2012-07-11 02:26:18

CULVER CITY, Calif., July 11, 2012 /PRNewswire/ -- Sofie Biosciences, Inc., a molecular imaging company offering a comprehensive range of products from preclinical imaging systems to novel diagnostic PET imaging probes, announced today that the Department of Energy has awarded the company a grant under the Small Business Innovation Research (SBIR) program. This Phase II award, for approximately $1M, will support the development of a microscale technology for rapid, easy synthesis of PET...

2012-07-11 02:24:58

SAN DIEGO, July 11, 2012 /PRNewswire/ -- On Friday, July 6, 2012, Imaging Healthcare Specialists became the first imaging center in San Diego County and among the first in the nation to offer patients PET brain imaging with Amyvid(TM), the radioactive agent which can detect the presence or absence of amyloid plaques in the brain as part of a diagnostic evaluation to determine if a patient has the pathology of Alzheimer's Disease (AD). Amyvid was FDA approved in April 2012 and released to...

2012-06-28 12:58:38

In a genome-wide association (GWA) study, researchers from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) have identified several genes which influence degeneration of the hippocampus, the part of the brain most associated with Alzheimer disease (AD). The study, which currently appears online as a Rapid Communication in the Annals of Neurology, demonstrates the efficacy of endophenotypes for broadening the understanding of the genetic basis of and pathways leading to...

Highways Of The Brain
2012-06-18 15:34:49

A new study proposes a communication routing strategy for the brain that mimics the American highway system, with the bulk of the traffic leaving the local and feeder neural pathways to spend as much time as possible on the longer, higher-capacity passages through an influential network of hubs, the so-called rich club. The study, published this week online in the Early Edition of the Proceedings of the National Academy of Sciences, involves researchers from Indiana University and the...